000 01526 a2200433 4500
005 20250514214859.0
264 0 _c20050222
008 200502s 0 0 eng d
022 _a0897-7151
024 7 _a10.1089/neu.2004.21.1443
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRingger, N C
245 0 0 _aA novel marker for traumatic brain injury: CSF alphaII-spectrin breakdown product levels.
_h[electronic resource]
260 _bJournal of neurotrauma
_cOct 2004
300 _a1443-56 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aBiomarkers
_xcerebrospinal fluid
650 0 4 _aBlotting, Western
650 0 4 _aBrain
_xmetabolism
650 0 4 _aBrain Injuries
_xcerebrospinal fluid
650 0 4 _aElectrophoresis, Polyacrylamide Gel
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aMagnetic Resonance Imaging
650 0 4 _aMale
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aRecovery of Function
650 0 4 _aSpectrin
_xcerebrospinal fluid
700 1 _aO'Steen, B E
700 1 _aBrabham, J G
700 1 _aSilver, X
700 1 _aPineda, J
700 1 _aWang, K K W
700 1 _aHayes, R L
700 1 _aPapa, L
773 0 _tJournal of neurotrauma
_gvol. 21
_gno. 10
_gp. 1443-56
856 4 0 _uhttps://doi.org/10.1089/neu.2004.21.1443
_zAvailable from publisher's website
999 _c15350838
_d15350838